555 Results
Sort By:
Published on February 3, 2017
Philadelphia Coalition for a Cure (PC4C) said today it will partner with Children's Hospital of Orange County (CHOC) on a study of brain tumors in adults and children that will use NantHealth’s GPS Cancer molecular profiling and diagnostics test. GPS Cancer integrates whole genome (DNA) sequencing of over 20,000 genes…
Published on January 30, 2017
Investigators from the Lund University Diabetes Centre in Sweden have been able to map the entire methylome in the insulin-producing pancreatic islets, measuring individual gene function and expression. The findings from this study were published recently in Diabetes through an article entitled “Whole-genome Bisulfite Sequencing of Human Pancreatic Islets Reveals…
Published on January 23, 2017
Genomic data analysis company Omicia announced the acquisition of Spiral Genetics for an undisclosed price, in a deal designed to enhance Omicia’s Opal clinical genomics software platform with Spiral’s secondary next-generation sequencing (NGS) analysis and structural variant capabilities. “We have come together to create the most advanced, end-to-end bioinformatics solution…
Published on January 18, 2017
Bio-Rad Laboratories has signaled its growing interest in digital PCR and liquid biopsy with its plans announced this week to acquire RainDance Technologies for an undisclosed price. “We look forward to expanding our offering to provide life science and clinical diagnostics customers with solutions for a wide range of nucleic…
Published on January 18, 2017
Johns Hopkins researchers have published new data that suggests epigenetic changes controlling how DNA operates, provides survival advantages to a subset of pancreatic cancer cells. The results, published in the Nature Genetics article, “Epigenomic Reprogramming during Pancreatic Cancer Progression Links Anabolic Glucose Metabolism to Distant Metastasis,” show that these changes…
Published on January 11, 2017
A new study by an international team of scientists lead by researchers at Columbia University Medical Center (CUMC), and New York-Presbyterian has just found that several genes previously implicated only in rare, severe forms of pediatric epilepsy also contribute to common forms of the disorder. The findings from the study…
Published on January 6, 2017
Three years after co-founding Human Longevity Inc., J. Craig Venter, Ph.D., will step down as CEO, but will remain executive chairman of the company he helped form to develop and apply large-scale computing and machine learning to discoveries aimed at revolutionizing medical practice. Succeeding Dr. Venter as CEO will be Cynthia Collins, who…
Published on November 1, 2016
A team of investigators led by scientists at St. Jude Children's Research Hospital and the Washington University Pediatric Cancer Genome Project (PCGP) has published a comprehensive map of the genomic landscape for the form of acute myeloid leukemia (AML) called core-binding factor acute myeloid leukemia (CBF-AML). This new work reveals…
Published on October 26, 2016
Twenty academic institutions, diagnostic and drug developers, and government agencies have begun creating an open database for liquid biopsy data—a pilot project of Vice President Joe Biden’s “Cancer Moonshot”—aimed at advancing development of blood profiling diagnostic technologies. The Blood Profiling Atlas pilot plans to aggregate, make freely available, and harmonize…
Published on August 23, 2016
NIH researchers have announced the discovery of a rare and sometimes deadly inflammatory disease, named Otulipenia, which affects primarily children and has a variety of symptoms including fever, skin rashes, diarrhea, joint pain, and overall failure of children to grow or thrive. The scientists also identified anti-inflammotory treatments for the…
Published on June 16, 2016
Understanding how the gut microbiome is established and by what means the combination of microbes in individual children may contribute to the risk of developing conditions like type 1 diabetes and inflammatory bowel disease is key to overall developmental health. Now, a research team led by investigators at Massachusetts General…
Published on June 2, 2016
The results from a unique new pilot program conducted by scientists from the Icahn School of Medicine at Mount Sinai show that multidimensional genomic profiles outperform the targeted cancer panels used currently in many clinical laboratories. The Mt. Sinai team developed and tested the personalized cancer therapy program using an…
Published on May 25, 2016
A new study led by researchers at The University of Texas MD Anderson Cancer Center has uncovered genetic mutations that could potentially fuel early cancer growth in precancerous colorectal tissue from high-risk patients. This is the first study to use whole-exome sequencing (WES) to characterize genetic changes in precancerous polyps…
Published on May 20, 2016
Often called degenerative joint disease or “wear and tear” arthritis, osteoarthritis (OA) is the most common chronic condition of the joints. It occurs when the cartilage or cushion between joints breaks down leading to pain, stiffness, and swelling. Joint injury may result in posttraumatic osteoarthritis (PTOA). In fact, about half…
Published on April 22, 2016
Human Longevity Inc. (HLI) will sequence and analyze up to 500,000 DNA samples from patients in AstraZeneca clinical trials over 10 years in one of four genomics-focused initiatives announced today by the pharma giant and its global biologics R&D arm MedImmune. The value of the collaboration with HLI and other…